Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.37 |
| ▸ | IL1B | P01584 | 1/20 | 0.35 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 2/20 | 0.33 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | KIF5B | P33176 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 4/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9741759 | 0.80 | TSHR (0.62) | CYP3A4TSHRRECQLRETKIF5B | |
| SCHEMBL21635491 | 0.77 | CYP3A4 (0.63) | CYP3A4TSHRRECQLADRA2AADRA2B | |
| SCHEMBL5512648 | 0.75 | KIF11 (0.36) | CYP3A4TSHRRECQLADRA2AADRA2B | |
| SCHEMBL29440029 | 0.73 | ESR1 (0.34) | ESR1ESR2 | |
| SCHEMBL19849657 | 0.73 | ESR1 (0.34) | ESR1ESR2 | |
| SCHEMBL18827200 | 0.70 | TRPM5 (0.50) | IL1BNLRP3MEN1MAPTRAB9A | |
| SCHEMBL2709499 | 0.70 | ADRA2A (0.46) | CYP3A4TSHRRECQLADRA2AADRA2B | |
| SCHEMBL7159847 | 0.70 | APP (0.43) | RECQLKIF11ESR1ESR2KDM4E | |
| SCHEMBL16280538 | 0.70 | ADRA2A (0.38) | CYP3A4TSHRRECQLADRA2AADRA2B | |
| SCHEMBL2709623 | 0.69 | PDK1 (0.44) | TSHRKDM4EMEN1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11275265-B2 | Control of illumination spectra for LCD displays | MOLECULED LTD. (IL) | 2022-03-15 | — | — | US | disclosed |
| US-10808127-B2 | Color conversion with solid matrix films and green rhodamines | MOLECULED LTD. (IL) | 2020-10-20 | — | — | US | disclosed |
| US-10808127-B2 | Color conversion with solid matrix films and green rhodamines | MOLECULED LTD. (IL) | 2020-10-20 | — | — | US | disclosed |
| US-10465110-B2 | Rhodamine based salts | StoreDot Ltd. (IL) | 2019-11-05 | — | — | US | disclosed |
| US-10465110-B2 | Rhodamine based salts | StoreDot Ltd. (IL) | 2019-11-05 | — | — | US | disclosed |
| US-10240042-B2 | Photoluminescent compounds and uses thereof | StoreDot Ltd. (IL) | 2019-03-26 | — | — | US | disclosed |
| US-10240042-B2 | Photoluminescent compounds and uses thereof | StoreDot Ltd. (IL) | 2019-03-26 | — | — | US | disclosed |
| US-10227492-B2 | Modifications of the sol-gel films and production processes thereof | StoreDot Ltd. (IL) | 2019-03-12 | — | — | US | disclosed |
| US-10227492-B2 | Modifications of the sol-gel films and production processes thereof | StoreDot Ltd. (IL) | 2019-03-12 | — | — | US | disclosed |
| US-10100197-B2 | Rhodamine derivatives dyes and uses thereof | StoreDot Ltd. (IL) | 2018-10-16 | — | — | US | disclosed |
| US-20180057688-A1 | RHODAMINE DERIVATIVES DYES AND USES THEREOF | MOLECULED LTD. (IL) | 2018-03-01 | — | — | US | disclosed |
| US-20180057689-A1 | RHODAMINE DERIVATIVES DYES AND USES THEREOF | StoreDot Ltd. (IL) | 2018-03-01 | — | — | US | disclosed |
| US-20180057689-A1 | RHODAMINE DERIVATIVES DYES AND USES THEREOF | StoreDot Ltd. (IL) | 2018-03-01 | — | — | US | disclosed |
| US-20180039131-A1 | CONTROL OF ILLUMINATION SPECTRA FOR LCD DISPLAYS | StoreDot Ltd. (IL) | 2018-02-08 | — | — | US | disclosed |
| US-20180037738-A1 | COLOR CONVERSION WITH SOLID MATRIX FILMS | StoreDot Ltd. (IL) | 2018-02-08 | — | — | US | disclosed |
| US-20180039131-A1 | CONTROL OF ILLUMINATION SPECTRA FOR LCD DISPLAYS | StoreDot Ltd. (IL) | 2018-02-08 | — | — | US | disclosed |
| US-20180037738-A1 | COLOR CONVERSION WITH SOLID MATRIX FILMS | StoreDot Ltd. (IL) | 2018-02-08 | — | — | US | disclosed |
| EP-2445969-B1 | NOVEL FLUORINATED RHODAMINES AS PHOTOSTABLE FLUORESCENT DYES FOR LABELLING AND IMAGING TECHNIQUES | MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V (DE) | 2014-08-27 | — | — | EP | disclosed |
| US-8735444-B2 | Fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2014-05-27 | — | — | US | disclosed |
| US-20120135459-A1 | NOVEL FLUORINATED RHODAMINES AS PHOTOSTABLE FLUORESCENT DYES FOR LABELLING AND IMAGING TECHNIQUES | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135459-A1 | NOVEL FLUORINATED RHODAMINES AS PHOTOSTABLE FLUORESCENT DYES FOR LABELLING AND IMAGING TECHNIQUES | SNRPD1, SRSF6, DRD1 | CYP3A4 3231/4885TSHR 1915/4885RECQL 472/4885 |
| US-10240042-B2 | Photoluminescent compounds and uses thereof | MAPRE2, TYR, IK | CYP3A4 978/4885TSHR 4048/4885RECQL 667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.